Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.1813
-0.0357 (-16.45%)
Oct 30, 2026, 12:31 PM EDT - Market open
SNTI Market Cap
SNTI has a market cap or net worth of $5.65 million as of October 30, 2026. It is the 43,465th most valuable company in the world and the 5,803rd biggest in the United States. Its market cap has decreased by 90.32% in one year.
Market Cap
5.65M
Enterprise Value
19.27M
1-Year Change
-90.32%
Global Rank
Country Rank
#5,803 United States
Category
ChartMarket Cap Chart
Since May 26, 2021, SNTI's market cap has decreased from $256.04M to $5.65M, a decrease of -97.79%. That is a compound annual growth rate of -50.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 6.54M | -76.08% |
| Dec 31, 2025 | 27.34M | 69.76% |
| Dec 31, 2024 | 16.11M | -45.22% |
| Dec 29, 2023 | 29.40M | -52.46% |
| Dec 30, 2022 | 61.84M | -78.72% |
| Dec 31, 2021 | 290.53M | 13.47% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Exicure | 6.55M |
| Enveric Biosciences | 6.49M |
| Aprea Therapeutics | 6.48M |
| Processa Pharmaceuticals | 6.33M |
| FibroBiologics | 6.33M |
| CNS Pharmaceuticals | 6.33M |
| Evogene | 5.93M |
| Skye Bioscience | 5.84M |